BXRX

Baudax Bio News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Baudax Bio Inc BXRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0043 0.57% 0.7599 19:58:07
Open Price Low Price High Price Close Price Prev Close
0.765 0.7228 0.765 0.745 0.7556
more quote information »

Recent News

Date Time Source Heading
8/03/202217:17EDGARSecurities Registration Statement (s-1)
7/08/202216:06EDGARCurrent Report Filing (8-k)
6/27/202217:25EDGARCurrent Report Filing (8-k)
6/17/202216:14EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202216:13EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202216:13EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202216:12EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202216:11EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202216:10EDGARStatement of Changes in Beneficial Ownership (4)
6/01/202208:00GLOBEBaudax Bio Announces Dosing of First Cohort in First-in-Man,..
5/27/202216:25EDGARStatement of Ownership (sc 13g)
5/20/202216:08EDGARCurrent Report Filing (8-k)
5/19/202206:08EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/18/202216:43EDGARCurrent Report Filing (8-k)
5/18/202208:00GLOBEBaudax Bio to Present at the H.C. Wainwright Annual Global..
5/17/202219:00GLOBEBaudax Bio Announces $2.0 Million Registered Direct Offering..
5/06/202208:05TRMNAnalysts Offer Insights on Healthcare Companies: Baudax Bio..
5/05/202217:16EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/05/202217:00GLOBEBaudax Bio Announces Date of Reconvened Annual Meeting of..
5/05/202207:04EDGARQuarterly Report (10-q)
5/05/202207:02EDGARCurrent Report Filing (8-k)
5/04/202217:00GLOBEBaudax Bio Reports First Quarter 2022 Financial Results and..
5/02/202216:05GLOBEBaudax Bio to Report First Quarter 2022 Financial Results..
4/27/202208:13TRMNNoble Financial Thinks Baudax Bio’s Stock is Going to..
4/26/202216:21EDGARInitial Statement of Beneficial Ownership (3)
4/20/202208:35EDGARCurrent Report Filing (8-k)
4/13/202208:00GLOBEBaudax Bio to Present at NobleCon18 Investor Conference
3/31/202216:11EDGARCurrent Report Filing (8-k)
3/17/202208:15TRMNNoble Financial Thinks Baudax Bio’s Stock is Going to..
3/16/202216:19EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/16/202216:17EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/16/202208:55SEEKBaudax Bio GAAP EPS of $10.03, revenue of $0.4M
3/16/202208:33EDGARAnnual Report (10-k)
3/16/202208:16EDGARCurrent Report Filing (8-k)
3/16/202208:00GLOBEBaudax Bio Reports 2021 Fourth Quarter and Annual Financial..
3/10/202207:00GLOBEBaudax Bio to Present at the Oppenheimer 32nd Annual..
3/08/202209:34SEEKBaudax Bio begins study of pain drug Anjeso in children..
3/08/202208:00GLOBEBaudax Bio Initiates Phase IV Clinical Trial Evaluating..
3/07/202208:18SEEKBaudax Bio regains compliance with Nasdaq's listing rules
3/07/202208:16EDGARCurrent Report Filing (8-k)
3/07/202208:00GLOBEBaudax Bio Regains Compliance with NASDAQ Listing..
3/02/202207:36SEEKBaudax Bio wins new U.S. patent for pain therapy
3/02/202207:00GLOBEBaudax Bio Announces Seventh Orange Book Listable Patent for..
3/01/202207:02EDGARCurrent Report Filing (8-k)
2/28/202217:29EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/25/202202:51SEEKBaudax Bio slumps 34% on pricing $10.0M stock and warrants..
2/24/202223:23GLOBEBaudax Bio Announces Pricing of $10.0 Million Public..
2/24/202216:59EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/24/202216:50SEEKBaudax Bio down 21% on launching stock offering
2/24/202216:40GLOBEBaudax Bio Announces Proposed Public Offering of Securities


Your Recent History
NASDAQ
BXRX
Baudax Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now